Clinical trial
Multi-Center Pilot Study to Evaluate Concentrated Bone Marrow Aspirate (cBMA) as a Treatment to Modify Post-Traumatic Osteoarthritis (PTOA) Following Revision Anterior Cruciate Ligament Reconstruction (ACLR)
NCT06311513 is registered in ClinicalTrials.gov with Hospital for Special Surgery, New York as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multi-Center Pilot Study to Evaluate Concentrated Bone Marrow Aspirate (cBMA) as a Treatment to Modify Post-Traumatic Osteoarthritis (PTOA) Following Revision Anterior Cruciate Ligament Reconstruction (ACLR)
- Lead sponsor
- Hospital for Special Surgery, New York
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- January 22, 2024
- Completion date
- December 31, 2028
- Enrollment
- 40 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
acl injury, anterior cruciate ligament injuries, bone marrow aspirate concentrate, post-traumatic osteoarthritis of knee